Ophthalmology stands at the forefront of gene therapy translation. The retina’s immune-privileged status, anatomically confined structure, and objectively quantifiable visual endpoints have made the ...
This article examines three critical operational challenges in clinical trials for chronic ophthalmic diseases such as age-related macular degeneration (AMD) and diabetic retinopathy (DR): patient rec...
I. Overview of Clinical Trial Endpoints for Common Ophthalmic DiseasesThe appropriate selection of endpoints in ophthalmic drug clinical trials directly determines the scientific validity of a study a...
